227 related articles for article (PubMed ID: 3803796)
21. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
[TBL] [Abstract][Full Text] [Related]
22. Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans.
Pak HN; Hong SJ; Hwang GS; Lee HS; Park SW; Ahn JC; Moo Ro Y; Kim YH
J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1357-63. PubMed ID: 15610278
[TBL] [Abstract][Full Text] [Related]
23. [Primary ventricular fibrillation].
Aliot E; Sadoul N; de Chillou C
Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):783-8. PubMed ID: 8267507
[TBL] [Abstract][Full Text] [Related]
24. [Arrhythmogenic right ventricular dysplasia. Study of a selected population].
Nava A; Martini B; Thiene G; Buja GF; Canciani B; Scognamiglio R; Miraglia G; Corrado D; Boffa GM; Daliento L
G Ital Cardiol; 1988 Jan; 18(1):2-9. PubMed ID: 3290027
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic value of exercise test in the evaluation of sustained ventricular arrhythmia].
Fareh S; Desseigne P; Champagnac D; Chevallier P; Kirkorian G; Touboul P
Arch Mal Coeur Vaiss; 1994 Jun; 87(6):751-6. PubMed ID: 7702418
[TBL] [Abstract][Full Text] [Related]
26. [Value of the isoprenaline test in arrhythmogenic heart diseases].
Haissaguerre M; Montserrat P; Le Métayer P; Barrat JL; Warin JF
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1845-53. PubMed ID: 2514636
[TBL] [Abstract][Full Text] [Related]
27. [Clinical electrophysiological evaluation of mexiletine].
Molina L; Colín L; Micheletti T; Blank S; Camacho J
Arch Inst Cardiol Mex; 1986; 56(3):219-23. PubMed ID: 2944491
[TBL] [Abstract][Full Text] [Related]
28. [Isotope angiocardiographic study of 30 cases of ventricular tachycardia with Fourier phase analysis].
Cosnay P; Fauchier JP; Philippe L; Casset D; Itti R; Moquet B; Mannara R; Huguet RG; Mustapha H
Arch Mal Coeur Vaiss; 1988 Apr; 81(4):463-74. PubMed ID: 3136707
[TBL] [Abstract][Full Text] [Related]
29. [Results of the systematic application of ventricular stimulation methods].
Perrot B; Thiel B; Cherrier F; Faivre G
Arch Mal Coeur Vaiss; 1984 Mar; 77(3):262-72. PubMed ID: 6424612
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of syncopes in arrhythmogenic right ventricular dysplasia-cardiomyopathy beyond monomorphic ventricular tachycardia.
Peters S; Trümmel M; Koehler B; Westermann KU
Int J Cardiol; 2006 Jan; 106(1):52-4. PubMed ID: 16321666
[TBL] [Abstract][Full Text] [Related]
31. [Ventricular rhythm disorders in congestive myocardiopathy].
Leclerq JF; Maisonblanche P; Cauchemez B; Attuel P; Coumel P
Arch Mal Coeur Vaiss; 1984 Aug; 77(8):937-45. PubMed ID: 6207793
[TBL] [Abstract][Full Text] [Related]
32. [Arrhythmogenic myocardiopathy of the left ventricle: dynamic ECG. Morphologic data and age of the patient in the prediction of the onset of arrhythmic events].
Rizzardo P; Nava A; Martini B; Buja G; Canciani B
Minerva Cardioangiol; 1990; 38(1-2):3-9. PubMed ID: 2342645
[TBL] [Abstract][Full Text] [Related]
33. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
34. [Transvenous ablation of recurrent ventricular tachycardia in arrhythmogenic right ventricular dysplasia].
Musiał WJ; Pitschner HF; Neuzner J
Kardiol Pol; 1993 Sep; 39(9):188-91; discussion 192. PubMed ID: 8231016
[TBL] [Abstract][Full Text] [Related]
35. [Arrhythmogenic dysplasia of the right ventricle: a cause of ventricular tachycardia in childhood].
García y Otero A; Iturralde P; Vázquez Antona C; Zabal C; Vargas J; López Valle H; Buendía Hernández A
Arch Inst Cardiol Mex; 1992; 62(1):77-81. PubMed ID: 1562213
[TBL] [Abstract][Full Text] [Related]
36. Significant myocardial pathology and increase of alpha 1-adrenergic receptor number affecting the arrhythmogenic condition in cases with ventricular tachycardia.
Hasumi M; Hiroe M; Fujita N; Hasumi S; Toyosaki T; Nagao H; Hosoda S; Kasajima T; Sekiguchi M
Heart Vessels Suppl; 1990; 5():31-6. PubMed ID: 1965541
[TBL] [Abstract][Full Text] [Related]
37. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study.
Tandri H; Macedo R; Calkins H; Marcus F; Cannom D; Scheinman M; Daubert J; Estes M; Wilber D; Talajic M; Duff H; Krahn A; Sweeney M; Garan H; Bluemke DA;
Am Heart J; 2008 Jan; 155(1):147-53. PubMed ID: 18082506
[TBL] [Abstract][Full Text] [Related]
38. [The arrhythmogenic right ventricular cardiomyopathy (ARVC)].
Wellemeyer K; Röthemeyer S; Kranig W; Grove R; Thale J
Z Kardiol; 2003 Dec; 92(12):1033-8. PubMed ID: 14663615
[TBL] [Abstract][Full Text] [Related]
39. [2 cases of arrhythmogenic dysplasia of the right ventricle of familial occurrence].
Conte MR; Marchese C; Anselmino M; Cervasel C; Gaita F; Rosettani E; Brusca A
G Ital Cardiol; 1987 Nov; 17(11):995-8. PubMed ID: 3446573
[TBL] [Abstract][Full Text] [Related]
40. [Arrhythmogenic right ventricular dysplasia and Uhl's disease].
Fontaine G; Guiraudon G; Frank R; Tereau Y; Fillette F; Marcus FI; Chomette G; Grosgogeat Y
Arch Mal Coeur Vaiss; 1982 Apr; 75(4):361-71. PubMed ID: 6808947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
